La maladie de Parkinson en France (serveur d'exploration) - Curation (Ncbi)

Index « Mesh.i » - entrée « Serotonin »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Serotonergic Neurons < Serotonin < Serotonin 5-HT1 Receptor Agonists  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 18.
Ident.Authors (with country if any)Title
000048 (????) S. Bourgoin [France] ; S. Rostaing-Rigattieri ; J P Nguyen ; E. Berberich ; P. Duvaldestin ; C M Fattaccini ; M. Hamon ; F. CesselinOpposite changes in dopamine metabolites and met-enkephalin levels in the ventricular CSF of patients subjected to thalamic electrical stimulation.
000062 (1999) O. Rascol [France]L-dopa-induced peak-dose dyskinesias in patients with Parkinson's disease: a clinical pharmacologic approach.
000361 (2003) Benjamin Di Cara [France] ; Denise Samuel ; Pascal Salin ; Lydia Kerkerian-Le Goff ; Annie DaszutaSerotonergic regulation of the GABAergic transmission in the rat basal ganglia.
000765 (2007) Stéphanie Mounayar [France] ; Sabrina Boulet ; Dominique Tandé ; Caroline Jan ; Mathias Pessiglione ; Etienne C. Hirsch ; Jean Féger ; Marc Savasta ; Chantal François ; Léon TremblayA new model to study compensatory mechanisms in MPTP-treated monkeys exhibiting recovery.
000B19 (2010) Sylvia Navailles [France] ; Abdelhamid Benazzouz ; Bernard Bioulac ; Christian Gross ; Philippe De DeurwaerdèreHigh-frequency stimulation of the subthalamic nucleus and L-3,4-dihydroxyphenylalanine inhibit in vivo serotonin release in the prefrontal cortex and hippocampus in a rat model of Parkinson's disease.
000C36 (2011) Sylvia Navailles [France] ; Philippe De DeurwaerdèrePresynaptic control of serotonin on striatal dopamine function.
000C52 (2011) Sylvia Navailles [France] ; Bernard Bioulac ; Christian Gross ; Philippe De DeurwaerdèreChronic L-DOPA therapy alters central serotonergic function and L-DOPA-induced dopamine release in a region-dependent manner in a rat model of Parkinson's disease.
000E14 (2011) Sylvia Navailles [France] ; Manolo Carta ; Martin Guthrie ; Philippe De DeurwaerdèreL-DOPA and serotonergic neurons: functional implication and therapeutic perspectives in Parkinson's disease.
000E19 (2012) C. Delaville [France] ; S. Navailles ; A. BenazzouzEffects of noradrenaline and serotonin depletions on the neuronal activity of globus pallidus and substantia nigra pars reticulata in experimental parkinsonism.
000E34 (2012) Sylvia Navailles [France] ; Philippe De DeurwaerdèreContribution of serotonergic transmission to the motor and cognitive effects of high-frequency stimulation of the subthalamic nucleus or levodopa in Parkinson's disease.
000E97 (2012) P. De Deurwaerdère [France] ; S. NavaillesWhat can we expect from the serotonergic side of L-DOPA?
000F25 (2012) David Grabli [France] ; Carine Karachi [France] ; Marie-Laure Welter [France] ; Brian Lau [France, États-Unis] ; Etienne C. Hirsch [France] ; Marie Vidailhet [France] ; Chantal François [France]Normal and pathological gait: what we learn from Parkinson’s disease
001111 (2013) M. Lagière [France] ; S. Navailles ; L. Mignon ; A. Roumegous ; M-F Chesselet ; P. De DeurwaerdèreThe enhanced oral response to the 5-HT2 agonist Ro 60-0175 in parkinsonian rats involves the entopeduncular nucleus: electrophysiological correlates.
001112 (2013) S. Navailles [France] ; M. Lagière [France] ; A. Contini [France] ; P. De Deurwaerdère [France]Multisite Intracerebral Microdialysis to Study the Mechanism of L-DOPA Induced Dopamine and Serotonin Release in the Parkinsonian Brain
001128 (2013) P. De Deurwaerdère [France] ; M. Lagière ; M. Bosc ; S. NavaillesMultiple controls exerted by 5-HT2C receptors upon basal ganglia function: from physiology to pathophysiology.
001349 (2014) Gurdal Sahin [Suède] ; Lachlan H. Thompson [Suède, Australie] ; Sonia Lavisse ; Merve Ozgur [Suède] ; Latifa Rbah-Vidal ; Frédéric Dollé ; Philippe Hantraye ; Deniz Kirik [Suède]Differential Dopamine Receptor Occupancy Underlies L-DOPA-Induced Dyskinesia in a Rat Model of Parkinson's Disease
001420 (2014) Safa Bouabid [France, Maroc] ; Claire Delaville [France] ; Philippe De Deurwaerdère [France] ; Nouria Lakhdar-Ghazal [Maroc] ; Abdelhamid Benazzouz [France]Manganese-Induced Atypical Parkinsonism Is Associated with Altered Basal Ganglia Activity and Changes in Tissue Levels of Monoamines in the Rat
001C96 (1993) P. Gaspar [France] ; A. Febvret ; J. ColomboSerotonergic sprouting in primate MTP-induced hemiparkinsonism.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/Mesh.i -k "Serotonin" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/Mesh.i  \
                -Sk "Serotonin" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Serotonin
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024